Peter Staib
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Genomic variations and chromosomal abnormalities
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
Papers in
- Hematology 60
- Acute Myeloid Leukemia Research 44
- Chronic Myeloid Leukemia Treatments 10
- Multiple Myeloma Research and Treatments 6
- Genetics 20
- Chronic Lymphocytic Leukemia Research 18
- Co-authors
- Torsten Haferlach (11 shared papers)Wolfgang Kern (9 shared papers)Susanne Schnittger (8 shared papers)Hubert L. Serve (7 shared papers)Thomas Büchner (9 shared papers)Wolfgang Hiddemann (9 shared papers)Claudia Schoch (10 shared papers)Helmut Löffler (3 shared papers)
- Journals
- Blood (22 papers)Leukemia (11 papers)Journal of Clinical Oncology (11 papers)Annals of Oncology (10 papers)Nature Communications (9 papers)
- Partner nations
- GermanyCanadaUnited States
In The Last Decade
Peter Staib
135 papers receiving 12.9k citations
Peter Staib's Hit Papers
Peers
Comparison fields: 5 of 127
- Genetics 2.8k
- Hematology 3.3k
- Cancer Research 2.5k
- Oncology 1.3k
- Pathology and Forensic Medicine 694
Countries citing papers authored by Peter Staib
This map shows the geographic impact of Peter Staib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Staib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Staib more than expected).
Fields of papers citing papers by Peter Staib
This network shows the impact of papers produced by Peter Staib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Staib. The network helps show where Peter Staib may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Staib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2401 |
| 2 | Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial Hit paper breakdown → | 2010 | 1567 |
| 3 | Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease Hit paper breakdown → | 2002 | 839 |
| 4 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 564 |
| 5 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 428 |
| 6 | 2012 | 359 | |
| 7 | 2011 | 322 | |
| 8 | Comprehensive molecular characterization of mitochondrial genomes in human cancers Hit paper breakdown → | 2020 | 319 |
| 9 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 315 |
| 10 | 2008 | 279 | |
| 11 | 2003 | 227 | |
| 12 | 2006 | 213 | |
| 13 | 2012 | 209 | |
| 14 | Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response Hit paper breakdown → | 2022 | 200 |
| 15 | 2020 | 190 | |
| 16 | 2012 | 177 | |
| 17 | 2005 | 165 | |
| 18 | 2015 | 156 | |
| 19 | 2003 | 153 | |
| 20 | 2006 | 153 |
About Peter Staib
Peter Staib is a scholar working on Hematology, Genetics, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 138 papers that have together received 13.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (44 papers), Chronic Lymphocytic Leukemia Research (18 papers), Cancer Genomics and Diagnostics (11 papers), Chronic Myeloid Leukemia Treatments (10 papers), Breast Cancer Treatment Studies (9 papers), Multiple Myeloma Research and Treatments (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Genetics (2.8k citations), Hematology (3.3k citations), Cancer Research (2.5k citations), Oncology (1.3k citations) and Pathology and Forensic Medicine (694 citations). Peter Staib has collaborated with scholars based in Germany, Canada and United States. Frequent co-authors include Torsten Haferlach, Wolfgang Kern, Susanne Schnittger, Hubert L. Serve, Thomas Büchner, Wolfgang Hiddemann, Claudia Schoch, Helmut Löffler, Martin Dugas and Christian Wuchter. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Annals of Oncology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.